AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2019
Mar 7, 2019
35124_dirs_2019-03-07_e6b9c605-ef77-4d9c-8029-57eedd907f89.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2019-03-06
Reporting Person: Fritz Frederick J. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-06 | Celssion Corporation Common Stock | P | 3400 | $2.1315 | Acquired | 21491 | Direct |
| 2019-03-06 | Celssion Corporation Common Stock | P | 3300 | $2.1273 | Acquired | 18050 | Indirect |
Footnotes
F1: The shares were purchased on the open market.
F2: Stock purchased by spouse. Mr. Fritz disclaims beneficial ownership of all shares held by his spouse.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18